A Phase I Study of GT300 in Healthy Subjects

Clinical trial NCT04963855 · UNKNOWN

Trial details

NCT number: NCT04963855
Sponsor: Generian Pharmaceuticals, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Lewy Body Disease

Start date: 2021-08-23
Primary completion: 2022-02-15
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.